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cells (HSCs) arise in the aorta-gonads-mesonephros
(AGM) region. We report here that blood flow is
a conserved regulator of HSC formation. In zebrafish,
chemical blood flowmodulators regulated HSC devel-
opment, and silent heart (sih) embryos, lacking a heart-
beat and blood circulation, exhibited severely reduced
HSCs. Flow-modifying compounds primarily affected
HSC induction after the onset of heartbeat; however,
nitric oxide (NO) donors regulated HSC number even
when treatment occurred before the initiation of
circulation, and rescuedHSCs in sihmutants.Morpho-
lino knockdown of nos1 (nnos/enos) blocked HSC
development, and its requirement was shown to be
cell autonomous. In the mouse, Nos3 (eNos) was ex-
pressed inHSCs in theAGM. IntrauterineNos inhibition
or embryonicNos3deficiency resulted ina reductionof
hematopoietic clusters and transplantable murine
HSCs. This work links blood flow to AGM hematopoi-
esis and identifies NO as a conserved downstream
regulator of HSC development.
INTRODUCTION
Definitive hematopoietic stem cells (HSCs) that are capable of
self-renewal and production of all mature blood lineages arise
during embryogenesis. Both the timing of HSC induction and the
gene programs regulating this process are well conserved across
vertebrate species (Orkinand Zon, 2008). Additionally, factors that
affect HSC specification during embryogenesis often similarly
function in HSC maintenance and/or recovery after marrow injury.
The identification of factors that regulate HSC induction during
embryogenesis is of significant therapeutic interest.736 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.Murine transplantation studies revealed that adult-type long-
term repopulating (LTR) HSCs arise in the aorta-gonads-meso-
nephros (AGM) region between embryonic day 10.5 (e10.5)
and e11.5 (Dzierzak and Medvinsky, 2008). Transplantable
HSCs localize to the ventral wall of the dorsal aorta and express
phenotypic markers of mesenchymal, endothelial, or hematopoi-
etic cell types. Runx1, commonly affected in childhood and adult
leukemia (Downing et al., 1993; Golub et al., 1995), is required for
the formation of functional HSCs (North et al., 1999, 2002; Wang
et al., 1996); its expression is highly conserved across vertebrate
species (Orkin and Zon, 2008). Based on the functional conser-
vation of AGM hematopoiesis from fish to man, an evolutionary
advantage or necessity for the production of stem cells within
the aorta must exist. To identify genes that regulate HSC forma-
tion, we conducted a chemical genetic screen for regulators of
runx1/cmyb+ cells in the zebrafish AGM at 36 hr postfertilization
(hpf). We have previously identified PGE2 as a potent regulator of
both HSC induction and marrow repopulation across vertebrate
species (North et al., 2007). The wnt pathway similarly regulates
stem cell production during embryogenesis, and genetically
interacts with PGE2 (Goessling et al., 2009). The identification
of novel regulators of this process will aid in connecting the
complex network of signaling pathways that control both HSC
development during embryogenesis and marrow regulation in
the adult.
Nitric oxide (NO) plays a key role in the regulation of vascular
tone, angiogenesis, and endothelial migration (Davies, 1995;
Lucitti et al., 2007). As HSCs are derived from hemogenic
endothelial cells within the dorsal aorta, NO produced locally in
endothelial cells could link blood flow and HSC formation. NO
has been detected in blood cells and extends replating ability
in hematopoietic culture, presumably by maintaining HSCs
in a quiescent state in vitro (Krasnov et al., 2008). While NO func-
tion in the adult hematopoietic stroma is thought to have a posi-
tive effect on hematopoiesis, data from knockout mice imply that
NO production is detrimental to hematopoietic repopulation and
recovery after injury (Michurina et al., 2004); this effect, however,
may be due to NO-related superoxide complexes induced by
irradiation (Epperly et al., 2007). The role of NO in HSC induction
in the vertebrate embryo is currently uncharacterized.
Here, we show that a diverse group of compounds that regu-
late blood flow affect the production of runx1/cmyb+ HSCs. In
general, compounds that increased blood flow enhanced HSC
number, whereas chemicals that decreased blood flow dimin-
ished HSCs. silent heart (sih) embryos that lack a heartbeat
and fail to establish blood circulation had impaired HSC forma-
tion. Compounds that increase NO production could modify
HSC formation when exposure occurred prior to the initiation
of circulation and rescue HSC production in sih mutants. Inhibi-
tion of NO production blocked the inductive effect of several
blood flow modulators on HSCs, suggesting that NO serves
as the connection between blood flow and HSC formation. In
the mouse, NO synthase 3 (Nos3; eNos) is expressed in AGM
endothelium and hematopoietic clusters, and marks LTR-
HSCs. Intrauterine Nos inhibition reduced transplantable
HSCs; similar results were found for the Nos3/ knockout
mice. Our work provides a direct link between the initiation of
circulation and the onset of hematopoiesis within the AGM
and identifies NO signaling as a conserved regulator of HSC
development.
RESULTS
Modulators of Blood Flow Regulate HSC Formation
A chemical genetic screen was conducted to identify regulators
of AGM HSC formation (North et al., 2007). Of the chemicals
found to regulate runx1 and cmyb coexpression by in situ hybrid-
ization at 36 hpf, several were known modulators of heartbeat
and blood flow. These compounds were categorized into distinct
classes on the basis of their hemodynamic mechanism of action
(Figure S1A available online). Well-established agonists and
antagonists of each category were secondarily screened for
effects on HSCs (Figures 1A–1L). The adrenergic signaling path-
ways affect both cardiac and vascular physiology. Exposure to
the a1-adrenergic blocker doxasozin (10 mM) enhanced HSCs
(58 increased [inc]/86 scored), while the a-agonist ergotamine
(10 mM) decreased HSC number (Figures 1B and 1H, 42
decreased [dec]/82). Similarly, the b1-adrenergic blocker meto-
prolol increased (49 inc/77) and the b1-agonist epinephrine
decreased runx1/cmyb staining (Figures 1C and 1I, 40 dec/70).
Changes in electrolyte balance potently regulate cardiac and
vascular reactivity. The Ca2+-channel blocker nifedipine
enhanced HSC formation (48 inc/85), while BayK8644 dimin-
ished HSC number (Figures 1D and 1J, 34 dec/79). The cardiac
glycoside digoxin, a modulator of Na+/K+ fluxes, also increased
HSCs (Figure 1G, 56 inc/79). NO is a well-established direct
regulator of vascular tone and reactivity, thereby influencing
blood flow. The NO donor S-nitroso-N-acetyl-penicillamine
(SNAP) (10 mM) caused a significant increase in HSC develop-
ment (69 inc/93). In contrast, the Nos inhibitor N-nitro-L-arginine
methyl ester (L-NAME) (10 mM) diminished runx1/cmyb expres-
sion (Figures 1E and 1K, 58 dec/90). Exposure to the angio-
tensin-converting enzyme (ACE) inhibitor enalapril decreased
HSC number (Figure 1F, 42 dec/81). These findings were corrob-
orated by qPCR for runx1 (Figure 1M).Conserved vascular responses of each chemical class
were demonstrated by in vivo confocal microscopy of fli:GFP;
gata1:dsRed transgenic zebrafish (n = 5/compound) at 36 hpf
(Figures 1N and S2) (Eddy, 2005). These data correlated with
prior zebrafish studies (Fritsche et al., 2000). Vasodilation of
the artery and vein was accompanied by increased passage
of total blood volume, as seen by digital motion analysis of
gata1+ red blood cells (RBCs; data not shown); vasoconstriction
caused RBCs to traverse only in single file. Together with the
in situ hybridization studies, these experiments reveal that
increases in vessel diameter typically were coincident with
increased runx1 expression, and vice versa.
We have previously utilized microarray analysis of sorted cell
populations isolated during various stages of embryogenesis to
document cell-type and developmental specificity of genes of
interest (North et al., 2007; Weber et al., 2005). We found
components of the NO (nos1), angiotensin (ace2, agtrl1a, agt),
and adrenergic signaling (adra2b, adra2 da, adra2c) pathways
expressed in the HSC compartment (Figure S1B). Most were
more highly expressed during the definitive wave of hematopoi-
esis after the onset of the heartbeat and circulation, consistent
with their role in regulating hemodynamic homeostasis. These
data confirm that vascular tone and flow-modifying compo-
nents are present and responsive to chemical manipulation
in the AGM and imply that modulation of blood flow could
have a significant impact on HSC formation during embryonic
development.
Absence of a Heartbeat Causes Failures
in Definitive HSC Development
In the zebrafish, the occurrence of vigorous blood circulation
through the tail is coincident with HSC formation in this region
(T.E.N. and L.I.Z., unpublished data). In order to establish the
importance of blood flow for initiation of HSC formation, we
examined sih mutant zebrafish embryos, which lack a heartbeat
due to a mutation in cardiac troponin T (Sehnert et al., 2002).
runx1/cmyb expression was dramatically reduced in sih/
embryos (Figures 2A and 2E, 69 dec/77). In contrast, the vascular
marker flk1 was minimally affected (Figures 2B and 2F), consis-
tent with previous observations (Isogai et al., 2003). ephrinB2,
a marker of arterial identity, was reduced in sih embryos (Figures
2C and 2G, 55 dec/74), while expression of the venous marker
flt4 was increased (Figures 2D and 2H, 33 inc/61). These results
were confirmed by qPCR (Figure 2I, p < 0.05, n = 3). In contrast,
benzidine staining for RBCs as well as in situ hybridization for the
erythroid marker globin and the myeloid markermyeloperoxidase
(mpo) show distribution differences due to lack of blood circula-
tion in sih mutants, but no gross quantitative changes (Fig-
ures 2J, 2K, and S3A–S3H). Myosin heavy chain (mhc), a marker
of somitogenesis, and the endodermal progenitor marker foxa3
were also not affected. These data demonstrate that the absence
of a beating heart and subsequent failure to establish circulation
specifically impairs arterial identity and HSC formation.
Nitric Oxide Signaling Can Affect HSC Formation prior
to the Initiation of Flow
To further investigate the role of circulation in the initiation of
HSC development, we exposed zebrafish embryos to bloodCell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc. 737
Figure 1. Modulation of Vascular Flow Affects HSC Formation in Zebrafish
(A–M) Effect of blood flow modifiers on runx1/cmyb+ HSC formation. Zebrafish were exposed to chemicals (10 mM) from 10 somites–36 hpf and subjected to
runx1/cmyb in situ hybridization. Photomicrographs were taken with Nomarski optics at 403magnification. Representative examples from after drug treatment
are shown.
(L) Effect of todralazine (10 mM; 67 inc/84).
(M) Effect of drug treatment on runx1 expression, quantified by qPCR (mean ± SD).
(N) Effect of drug treatment on the diameter of the dorsal aorta in vivo. Transgenic fli:GFP fish were treated with chemicals and imaged by confocal microscopy at
36 hpf; all treatments were statistically significant from the control (mean ± SD, ANOVA, p < 0.001).flow-modulating agents either before (10 somites–23 hpf) or after
(26–36 hpf) the onset of heartbeat and assessed HSC develop-
ment at 36 hpf. All compounds examined increased HSC forma-
tion when used after the heartbeat began (Figures 3A, 3C, 3E,
and 3G). In contrast, only SNAP was capable of enhancing
HSC number at 36 hpf when treatment was completed before
the heartbeat was established (Figures 3B, 3D, and 3F). Like-
wise, the NO inhibitor L-NAME could reduce HSC formation
when treatment occurred prior to the initiation of the heartbeat
(Figure 3A). The effects of L-NAME and SNAP were dose depen-
dent over a range of 1–100 mM (Figures S4A–S4L) and specific to738 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.the HSC compartment, with mild effects on the vasculature, but
not on globin, mpo, mhc, or foxa3 expression (Figures S5A–
S5R). Additionally, changes were only observed during the defin-
itive hematopoietic wave and were maintained into larval stages
(Figures S6A–S6O). In addition to SNAP (Figure 3K, 18 inc/25),
NO donors sodium nitroprusside (SNP; Figure 3N, 20 inc/31)
and L-arginine (L-arg; Figure 3I, 15 inc/25) (Pelster et al.,
2005; Pyriochou et al., 2006) enhanced runx1/cmyb expression
(Figures 3I, 3K, and 3N), while the nonspecific nos inhibitor,
N-monomethyl-L-arg acetate (L-NMMA; Figure 3O, 17 dec/29)
diminished HSCs like L-NAME (Figure 3L, 16 dec/26). Inactive
Figure 2. A Beating Heart Is Required for
HSC Formation and Artery Development
(A–H) Effect of sih mutation on HSC and vascular
formation at 36 hpf.
(A and E) runx1/cmyb expression is greatly
reduced in sih/ embryos compared to WT
siblings.
(B and F) flk1 expression reveals a grossly normal
vascular pattern in sih/ embryos; changes in the
development of the intersomitic vessels and
vascular plexus were noted in some animals.
(C and F) ephB2 expression is diminished in sih/
embryos.
(D and H) flt4 expression is expanded in sih/
embryos.
(I) The expression levels of HSC (runx1, cmyb),
vascular (flk), and arterial (ephB2) markers
are significantly decreased in sih/ embryos
compared to sibling controls (mean ± SD, t test,
p < 0.05, n = 3), as measured by qPCR at 36 hpf.
(J and K) The sih mutation has no effect on primi-
tive hematopoiesis as seen by benzidine staining
at 36 hpf; in the absence of a heartbeat blood is
pooled in the major vessels.D-enantiomers had no effect (Figures 3J, 3M, and 3P). To assess
whether modification of runx1/cmyb expression correlated with
a quantifiable effect on HSC number, we utilized cmyb:GFP;
lmo2:dsRed reporter fish (North et al., 2007). Confocal micros-
copy revealed increased HSC (yellow) numbers after SNAP
exposure, and a reduction after L-NAME treatment (Figures
3Q–3S and S5S, p < 0.001, n = 5). TUNEL analysis indicated
that L-NAME could affect HSC by induction of apoptosis (Fig-
ures S7A–S7D). These analyses indicate that HSC modulation
by the majority of flow-modifying compounds requires the estab-
lishment of blood circulation and that NO signaling is the medi-
ator of blood flow in this process.
HSCFormation IsAffected bySignalsDownstreamofNO
To clarify that the effect of flow on HSCs was mediated by
NO signaling, we studied downstream components of the
NO signaling cascade by chemical manipulation. The soluble
guanyl cyclase inhibitor 1H-oxadiazolo-quinoxalin-1-one (ODQ)
prevents cGMP formation in response to NO signaling; it regu-
lates vascular remodeling and blood flow in zebrafish in
a dose- and time-dependent manner (Pyriochou et al., 2006).
ODQ (10 mM) caused a profound decrease in HSCs (Figures 3T
and 3U, 27 dec/43) and also blocked the effects of SNAP
(Figures 3W and 3X, 8 inc/38). Phosphodiesterase (PDE) V
converts cGMP to GTP. The PDEV inhibitor 4-{[30,40-methy-
lene-dioxybenzyl]amino}-6-methoxyquinazoline (MBMQ, 10 mM)
increased HSCs (Figure 3V, 35 inc/43) and further enhanced the
effects of SNAP (Figure 3Y, 40 inc/46). These data highlight the
specificity of cGMP as a downstream effector of NO signaling
in HSC formation.NO Signaling Rescues HSCs in sih/ Embryos
To confirm a direct role for NO in HSC induction, we exposed sih
embryos to SNAP. SNAP rescued runx1/cmyb expression
toward wild-type (WT) levels in the majority of sih embryos exam-
ined (Figures 4A–4D, 31 normal/51). These results were
confirmed by qPCR (Figure 4E). SNAP also normalized ephB2
defects in sih mutants (Figures 4F–4I, 18 inc/27; Figure S8A).
L-arg and SNP (data not shown), as well as bradykinin, a potent
vasodilator that stimulates NO production, increased HSCs, and
rescued the sih hematopoietic defect (Figures S8B–S8E). To
further characterize the relationship between blood flow, NO
signaling, and HSC induction, we concomitantly exposed WT
embryos to flow-modifying drugs and L-NAME (10 mM). As the
majority of flow-regulating compounds that enhance HSCs
also cause vasodilation and increase total blood flow through
the aorta, they may directly trigger NO production by alterations
in sheer stress, pulsatile flow, or soluble signaling components.
L-NAME treatment prevented the increase in HSC formation
caused by most compounds tested (Figures 4J–4U). These
data further point to NO signaling as the direct link between
blood flow and HSC development.
Nos1 Is Required for HSC Formation
Zebrafish lack genomic evidence for endothelial NO synthase
(enos, nos3); however, we, and others (Pelster et al., 2005),
observed eNos immunoreactivity in the tail region, where the
HSCs develop (Figures S9J–S9L). Phylogenetic and genomic
examination demonstrates that neuronal nos (nnos, nos1)
(Poon et al., 2003) and nos3 (enos) are highly related. Morpholino
antisense oligonucleotide (MO) knockdown of nos1 had aCell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc. 739
profound dose-dependent impact on HSC development (Figures
5A, 5C, and 5E; 63 dec/89 ATG MO, 48 dec/64 splice MO; Fig-
ures S9A–S9E), while knockdown of nos2 (inducible nos, inos)
did not affect runx1/cmyb expression (Figures 5D, and 5F;
9 dec/98 ATG MO, 10 dec/65; Figures S9F–S9I). The potent
effect of nos1 was confirmed by chemical inhibition of NO
synthesis (Figures 5B, 5G, and 5H): selective inhibition of nos1 by
S-methyl-L-thiocitrulline (10 mM; 30 dec/44) severely diminished
HSC number, whereas the nos2 (inos)-specific inhibitor 1400W
(10 mM; 4 dec/49) only minimally affected HSCs. These data
suggest that nos1 (nnos/enos) is required for HSC formation in
zebrafish, which is supported by nos1 expression in both endo-
thelial cells and HSCs (Figure S1B). Interestingly, in sih/
embryos, nos1was significantly decreased (Figure 5I, p < 0.001);
in contrast, nos2 was not significantly changed. Further, nos1,
but not nos2, was significantly altered in response to chemical
Figure 3. NO Signaling prior to the Onset of
Cardiac Activity can Affect HSC Formation
(A–G) Effect of vasoactive drugs (10 mM) on HSC
formation before and after the onset of heartbeat
at 24 hpf, after exposure to chemicals from either
10 somites–23 hpf or from 26–36 hpf.
(A) Most vasoactive drugs do not affect
HSC formation when applied prior to the onset of
heartbeat, while NO modifiers influenced HSC
development even prior to heart beat initiation.
The percentage of embryos (n > 20) with altered
runx1/cmyb expression is indicated.
(B–G) Representative examples of flow-modifying
drugs on runx1/cmyb expression.
(H–P) Specificity of NO signaling in HSC formation.
NO donors enhanced and inhibitors diminished
HSCs; inactive D-enantiomers had no effect.
(Q–S) Effects of NO modulation on HSC number
by in vivo confocal imaging in cmyb:GFP; lmo2:
dsRed transgenic embryos.
(T–Y) Effects of downstream modifiers of NO
signaling on runx1/cmyb expression.
(U and X) Inhibition of soluble guanyl cyclase by
ODQ (10 mM) decreases runx1/cmyb expression
in WT and SNAP treated embryos.
(V and Y) Inhibition of PDE V by MBMQ (10 mM)
increases HSC formation in WT embryos and
further enhances the effects of SNAP.
alteration of blood flow (Figures 5J and
5K, p < 0.003). These data support the
hypothesis that nos1 is the functionally
relevant connection between blood flow
and HSC development.
The Effect of NO Signaling on HSC
Formation Is Cell Autonomous
In order to examine cell autonomy and
delineate the role of NO signaling in the
HSC and surrounding hematopoietic
niche, we employed a blastula transplant
strategy. Cells harvested from cmyb:GFP
embryos injected with control or nos1 MO were transplanted at
the blastula stage into lmo2:dsRed recipients. In this transplant
scheme, donor-derived HSCs appear green (Figure S10A) in
the red fluorescent endothelial/HSC compartment (Figures 6A
and S10B). Sixty-two and a half percent of embryos examined
had GFP+ HSC formation derived from control-injected donor
cells (Figures 6B and 6D), while none of the nos1 MO injected
donor cells gave rise to green HSCs (Figures 3C and 3D, p =
0.0065); successful transplants were indicated by the contribu-
tion of cmyb+ donor cells to the recipient eye. In a reciprocal
experiment, we found that uninjected lmo2:dsRed donor cells
contributed to endothelial and HSC development in cmyb:GFP
recipients (Figure S10C), particularly after MO knockdown in
the recipient. These experiments formally demonstrate that
nos1 acts in a cell-autonomous manner in the hemogenic
endothelial cells.740 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.
Figure 4. NO Signaling Affects Zebrafish HSC Formation Independent of Heartbeat
(A–I) WT and sih/ mutants were exposed to DMSO and SNAP (10 mM) from 10 somites–36 hpf.
(A–D) In situ hybridization for runx1/cmyb. SNAP rescues HSC formation in sih/ mutants.
(B) Remaining runx1/cmyb+ cells are highlighted by arrowheads.
(E) qPCR for runx1. * statistically significant versus the WT, mean ± SD, ANOVA, p < 0.001, n = 5.
(F–I) Effect of heartbeat and SNAP on ephrinB2 expression, highlighted by arrowheads.
(J–U) Effect of L-NAME on HSC formation in embryos concurrently treated with blood flow-modifying agents. L-NAME inhibits the effects of doxazosin ([M],
7 inc/36 observed), metoprolol ([O], 3 inc/31) and nifedipine ([Q], 4 inc/28), but not of digoxin ([S], 16 inc/ 29) and todralazine ([U], 20 inc/33).Developmental Signaling Pathways Interact with NO
in HSC Formation
Developmental regulators such as the notch and wnt pathways
have been linked to HSC formation and self-renewal (Burns
et al., 2005; Goessling et al., 2009). Due to the effect of NO on
HSC specification and expansion, potential interaction with
notch and wnt signaling was examined. The notch pathway influ-
ences arterial/venous identity and functions upstream of runx1 in
HSC specification;mindbomb (mib) mutants lack HSCs because
of a deficiency of notch signaling (Burns et al., 2005) (33 dec/47).
SNAP rescued HSC formation in these mutants (Figures S11A–S11D; 27 normal/43). Transgenic zebrafish embryos expressing
an activated form of the notch intracellular domain (NICD) exhibit
enhanced HSC numbers (55 inc/62); L-NAME blocked the HSC
increase (Figures S11E–S11H; 16 inc/63) and inhibited NICD-
mediated elevation of ephB2 expression in the aorta (Figures
S12A–S12D). These studies imply that NO functions downstream
of notch in regulation of arterial identity and/or in HSC induction.
Recent studies have shown that modulation of the wnt
pathway affects HSCs (Goessling et al., 2009; Reya et al.,
2003). We used heat-shock-inducible transgenic zebrafish
embryos expressing negative (dkk) and positive (wnt8) regulatorsCell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc. 741
ofwntsignaling toevaluate the interactionbetween the wntand NO
signaling cascades (Goessling et al., 2008). Induction of dkk
reduced HSC number (16 dec/8) and was rescued by SNAP
(Figures S13A–S13D; 5 dec/33). In contrast, wnt8 enhanced HSC
formation (22 inc/30), which was blocked by L-NAME (Figures
S13E–S13H; 9 inc/28). In support of these findings, previous
studies have shown an interaction of both the notch and wnt path-
ways with NO, although the directionality of these interactions
varies (Du et al., 2006; Ishimura et al., 2005; Prevotat et al., 2006).
The Relationship between NO and HSC Induction
Is Conserved in the Mouse
To document a role for NO in murine HSC formation, we exam-
ined Nos3:GFP expression in the AGM. Histological sections of
e11.5 embryos showed endothelial cells lining the dorsal aorta
Figure 5. nos1 Is Required for HSC Forma-
tion in Zebrafish
(A–H) In situ hybridization for runx1/cmyb at 36 hpf.
(C and E)nos1 knockdown (40mM) decreased HSC
formation.
(D and F) MO (ATG and splice site) against nos2
(40 mM) had no effect on HSC development.
(B, G, and H) Chemical nos inhibition confirmed
the specific requirement for nos1: embryos
exposed to nonspecific (L-NAME; 10 mM) and
nos1-selective (S-methyl-L-thiocitrulline; 10 mM)
inhibitors demonstrated decreased HSC forma-
tion; nos2-selective inhibition (1400W; 10 mM)
had minimal impact.
(I) WT and sih/ embryo extracts (n = 20) were
subjected to qPCR (mean ± SD; * nos1, WT versus
sih, t test, p < 0.001, n = 3; nos2, WT versus sih,
p = 0.385, n = 3.).
(J and K) Effect of flow-modifying chemicals
(10 mM, 10 somites–36 hpf) on nos1 and nos2
expression; nos1 is significantly regulated by
most compounds tested. Mean ± SD; * significant
versus control, ANOVA, p < 0.01, n = 3.
expressing high levels of Nos3 (Figures
S14A–S14D). Hematopoietic clusters
and adjacent endothelium on the ventral
wall of the aorta expressed Nos3 at a
lower level; this expression pattern was
reminiscent of the embryonic HSC
markers such as Runx1 and c-Kit (North
et al., 2002). Fluorescence-activated
cell sorting (FACS)-based coexpression
analysis confirmed that the majority of
e11.5 cKithiCD34medCD45medVE-cadher-
inmed AGM HSCs (E.D., unpublished
data) were Nos3med (Figure S14E). Trans-
plantation of Nos3 AGM subfractions into
irradiated adult recipients demonstrated
that LTR-HSCs are enriched within the
Nos3med population (Figure S14F).
To demonstrate a conserved functional
requirement for NO signaling in HSC/
progenitor formation, we exposed preg-
nant mice to L-NAME (2.5 mg/kg intraperitoneally) or vehicle
control and compared effects on the AGM HSC and progenitor
populations at e11.5. NO inhibition produces implantation
defects in early pregnancy (Duran-Reyes et al., 1999) and can
alter yolk sac angiogenesis (Nath et al., 2004); interestingly,
Nos3 deficiency caused significant lethality from e8.5 to 13.5
during the time when definitive HSCs are formed (Pallares
et al., 2008). L-NAME treatment at e8.5 produced severely de-
layed embryos that lacked the majority of both extra- and intra-
embryonic blood vessels (data not shown). L-NAME treatment at
e9.5 and e10.5 at prevented gross morphological abnormalities
of the yolk sac, placenta, or embryo. Histological analysis of the
AGM region revealed that L-NAME caused the disappearance of
hemogenic endothelial clusters, which was confirmed by pheno-
typic FACS analysis (Figures 7A–7L and S15A–S15G). Similarly,742 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.
Figure 6. The Effect of NO Signaling on HSC Development Is Cell Autonomous
(A) Cells from cmyb:GFP transgenic donor embryos, injected with nos1 ATG MO or control MO, were transplanted into lmo2:dsRed recipients at the blastula
stage.
(B) Donor contribution to HSC formation assessed by confocal microscopy at 36 hpf. Shown are the merged picture on the top, red/green merge in the middle,
and a high-magnification view of green fluorescence only on the bottom. cmyb:GFP donor-derived HSCs in recipients are highlighted by arrowheads.
(C) nos1 MO donors never contributed to HSC formation; the presence of cmyb:GFP-derived donor cells in the eye is indicative of a successful transplant.
(D) HSC chimerism in transplanted embryos (control versus nos1 MO, Fisher’s exact test, p = 0.0065, nR 8).analysis of e11.5 Nos3/ embryos revealed a significant
decrease in the AGM Sca1+/cKit+ and CD45+/VE-Cadherin+
populations, which was confirmed histologically; Nos3/
embryos displayed a reduction in the number and size of the
hematopoietic clusters (Figure 7K). HSC induction was grossly
normal in Nos1/ animals (Figure 7L).
To examine effects on HSC function, we performed transplanta-
tion studies using single-cell suspensions of subdissected AGM
tissue from WT, L-NAME-exposed, and Nos3/ embryos at
e11.5. Progenitor activity as measured by spleen colony formation
at days 8 and 12 after transplantation was diminished in L-NAME-
exposed (Figure S15J, p < 0.001) and Nos3/ (Figure 7M, p <
0.001) embryos. Multilineage repopulation after 6 weeks revealedsignificantly diminished peripheral blood (PB) chimerism (Figures
7N and S15K, p > 0.05) and engraftment rates (Figure S15L) for
recipients of both L-NAME-exposed and Nos3/ AGM cells.
These results indicatea conserved role for NO signaling in the regu-
lation of hematopoietic stem/progenitor formation and function
during embryonic development. Although at reduced numbers,
Nos3/ embryos develop to adulthood and lack significant
steady-state peripheral blood abnormalities; our data suggest
that while impaired initially, some functional HSCs do arise in
Nos3/ embryos. Interestingly, although the Nos3/ animals
exhibit some residualHSCproduction, L-NAME-exposedembryos
do not possess AGM HSCs, implying that functional redundancy
with other Nos family members must occur.Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc. 743
Figure 7. The Effect of NO Signaling on HSC Development in the AGM Is Conserved in Mice
(A–H) FACS analysis of dissociated AGM cells in WT andNosKO mice at e11.5.Nos3/ mice exhibited a decrease in the Sca1+/cKit+ and CD45+/VE-Cadherin+
populations, while deletion of Nos1 had no significant effects.
(I–L) Histological sections through the AGM region of e11.5 embryos; the inset represents a high-magnification view around the hematopoietic clusters. L-NAME
exposure causes absence of hematopoietic clusters; Nos3/ mice exhibit smaller cluster size, while Nos1/ does not impair cluster formation. Serial sections
through the entire aorta of at least ten embryos per genotype/treatment were analyzed.
(M and N) Effect of NO signaling on AGM HSC function. AGM regions of somite stage-matched WT, L-NAME treated or Nos3/ progeny were subdissected at
e11.5 and transplanted into sublethally irradiated recipients. L-NAME exposure orNos3 deletion in embryos significantly reduced CFU-S12 spleen colony forma-
tion (mean ± SD; * sig versus control; p < 0.001; ** sig versus L-NAME; p < 0.05; ANOVA, nR 5) (M). Diminished NO signaling significantly decreased embryonic
donor cell chimerism rates in individual recipient mice at 6 weeks after transplant (* sig versus control, p < 0.05, ANOVA, nR 5) (N).744 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.
DISCUSSION
The purpose of a beating heart and circulation at embryonic
stages where diffusion is still sufficient for oxygenation of devel-
oping tissue has long been a source for speculation (Burggren,
2004; Pelster and Burggren, 1996). Through a chemical screen
in zebrafish, small molecules that regulate vascular dynamics
were found to influence HSC development; intriguingly, changes
in HSC formation were coupled to blood flow and NO produc-
tion. Our data imply that circulation itself, through NO induction,
signals to trigger the onset of definitive hematopoiesis, thereby
ensuring proper timing of blood cell development to support
additional hematopoietic requirements during accelerated
growth in fetal/larval stages. Significantly, we found that the
enhancing role of NO in HSC induction is conserved from fish
to mammals.
NO production can be induced by sheer stress and alterations
in blood flow (Fukumura et al., 2001). The coincident timing of
HSC induction with the achievement of vigorous pulsatile flow
implies that the latter may serve as the physiologic inductive
signal for NO in the AGM. Pulsatile flow achieved by a regular
heartbeat has been shown to trigger NO production in the endo-
thelium (White and Frangos, 2007). The data from the silent heart
embryos—as well as observations in Ncx1/ mice (Lux et al.,
2008; Rhodes et al., 2008), which also fail to establish circulation
due to heart-specific defects—indicate that in the absence of
flow there are alterations in specification, budding, and shedding
of HSCs from endothelial hematopoietic clusters. It will be
intriguing to further decipher the correlation between flow rate
and total AGM HSC number; MO knockdown of tnnt2 (sih) (Ber-
trand et al., 2008; Murayama et al., 2006; Jin et al., 2009) and
analysis of incompletely penetrant sih mutants with occasional
heartbeats (data not shown) show less-severe reductions in
HSC number, implying that small bursts of NO production may
be sufficient to trigger HSC induction. As NO can regulate endo-
thelial cell movement and processes resembling HSC budding,
such as podokinesis, by altering cell-cell adhesions and actin
conformation (Noiri et al., 1998), it could directly control the
formation and stability of hematopoietic clusters once flow is es-
tablished. Confirming this conjecture, we determined that there
is a cell-autonomous role of NO signaling during hematopoietic
development, where the hemogenic endothelial population
must be capable of NO production to support subsequent
HSC formation in the AGM.
We found that NO may additionally function to establish the
AGM vascular niche prior to HSC formation; our data showing
significant alterations in ephrinB2 staining in the absence of
flow support the concept that flow itself plays a role in maintain-
ing vascular identity. NO is a well-characterized regulator of
angiogenesis and is required for murine yolk sac vasculogenesis
(Nath et al., 2004). Prior studies in the zebrafish embryo showed
that chemical inhibition of NO production/signaling by L-NAME
or ODQ during somitogenesis produces vascular abnormalities
(Pyriochou et al., 2006). Since definitive HSCs are formed within
the major embryonic arteries (de Bruijn et al., 2000), any alter-
ations in NO signaling and subsequent vessel development
would negatively impact HSC number. As ephrinB2 and arterial
identity are established by notch signaling (Lawson et al.,2001), the interaction of the notch and NO pathways may be
particularly relevant for HSC formation. NO may initiate arterial
specification early during development and may maintain arterial
identity once flow is established. This is in agreement with
reports that demonstrate that arterialization is an ongoing and
flow-dependent process, influenced by NO (Teichert et al.,
2008). Similarly, vascular endothelial growth factor (VEGF),
a potent vascular mitogen regulated by both notch and wnt, is
a well-characterized inducer of NO production (Fukumura
et al., 2001). In the dorsal aorta, VEGF may increase NO produc-
tion and signaling to cause the vascular remodeling required for
the production of the hematopoietic clusters.
Our data demonstrate both a requirement for and enhancing
response to NO signaling for AGM HSC development. Several
nos isoforms have been identified in zebrafish: nos1, which is ex-
pressed in developing neural tissues as well as the gut, kidney,
and major vessels (Holmqvist et al., 2004; Poon et al., 2003),
and two isoforms of nos2. While genomic evidence for the pres-
ence in zebrafish of nos3 is lacking (Pelster et al., 2005), immu-
noreactivity to eNos antibodies suggests the conservation of
the functional epitope (Fritsche et al., 2000). As NO-mediated
vascular reactivity is clearly present in fish and nos1 and nos3
are highly related at both the sequence and structural levels,
nos1 likely assumes the role of vascular NO production in fish.
Nos1 is genetically complex with individual splice forms showing
tissue-specific expression, and it is likely that one form of nnos
acts enos-like in zebrafish. In support of this hypothesis, our
microarray analysis demonstrated nos1 expression in CD41+
HSCs and the vascular niche.
In the murine AGM, phenotypic and histological analysis
showed that Nos3 (eNos) is expressed in HSCs and required
for stem cell function. Conversely, we found Nos1 (nNos) not to
be essential for HCS formation under normal developmental
conditions. Interestingly, Nos3 and Nos1 are both expressed in
the fetal liver shortly after AGM HSC formation and could play
a role in the developmental regulation and expansion of HSC
and progenitor populations (Krasnov et al., 2008). Their coex-
pression suggests a functional redundancy in mammalian
HSCs that could explain the impaired, but present, HSC forma-
tion and adult viability of Nos3/ embryos. Consequently,
global NO inhibition by L-NAME had a much more severe effect
on HSC formation. It remains to be determined whether differ-
ences in hematopoietic development occur in mice in which all
Nos isoforms are disrupted.
NO donors positively affect multipotent hematopoietic progen-
itors in vitro (Michurina et al., 2004); additionally, the ability of
stromal cell lines to support stem cell maintenance corresponds
with NO production (Krasnov et al., 2008). In contrast, others have
shown that NO inhibition enhances HSC engraftment after trans-
plantation (Krasnov et al., 2008; Michurina et al., 2004). While
these studies imply that NO may have a negative effect on adult
HSCs, parallel work has shown that NO is induced by ionizing
irradiation and that the absence of Nos diminishes superoxide
and peroxide damage (Epperly et al., 2007). These data preclude
a clear interpretation of transplantation/repopulation studies
where the hematopoietic niche is cleared via irradiation. After
5-fluorouracil bone marrow injury, Nos3/ mice show impaired
regeneration, indicating an important role for Nos3 in stem andCell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc. 745
progenitor cell function in vivo after marrow injury (Aicher et al.,
2003). Taken together with the results presented here, these
studies indicate that the effects of NO are likely highly time and
context dependent, and further work is needed to decipher the
role of NO in regulating adult hematopoietic homeostasis and
maintaining both the stromal and vascular niche.
Our study demonstrates that definitive hematopoietic stem
cell formation in the developing embryo is dependent on the
induction of the heartbeat and establishment of circulation.
Two models have been proposed for the relationship of blood
formation in murine extraembryonic tissues and the embryo
proper: in one model, the stem cells arise independently in
discrete locations in the embryo and extraembryonic tissues
and subsequently colonize the fetal liver (Dzierzak and Speck,
2008; Rhodes et al., 2008), whereas the other proposes that cells
from the extraembryonic tissues traverse circulation to colonize
the intraembryonic hematopoietic sites (Palis and Yoder, 2001).
A recent study using the Ncx1/ mouse showed that yolk sac
hematopoietic progenitors could form in the absence of blood
flow, while the appearance of progenitors in the embryo proper
was greatly impaired; these data were interpreted to show that
it is yolk sac-derived embryonic progenitors that traverse the
circulation and seed the fetal liver (Lux et al., 2008). Our data
imply that the contemporaneous establishment of circulation
and the appearance of HSCs within the embryo proper may
not simply reflect the transit of HSCs formed in extraembryonic
tissues to colonize the aorta and fetal liver, but rather that the
circulation functions directly to provide inductive signals to
specific regions of the embryonic vasculature, making it compe-
tent to produce HSCs de novo.
Here, we established a conserved role for NO in the devel-
oping hematopoietic system. NO can function in vessel forma-
tion and specification, blood flow regulation, and hematopoietic
cluster formation, suggesting that it is required in the vascular
niche for HSC production. Although the function of NO in the
adult marrow is complex, our findings during embryogenesis
indicate that modulation of blood flow or NO signaling might




Zebrafish were maintained according to Institutional Animal Care and Use
Committee protocols. fli:GFP, hs:gal4;uas:NICD, wnt8:GFP, dkk1:GFP trans-
genic and sih and mib mutant fish were described previously (Burns et al.,
2005; Goessling et al., 2009; Itoh et al., 2003; Lawson and Weinstein, 2002;
Sehnert et al., 2002). Embryonic heat shock was conducted as described
(Goessling et al., 2009).
Mice
Embryos were generated from C57Bl/6, Runx1:lacZ (North et al., 1999),
Nos3:GFP transgenic (van Haperen et al., 2003), Nos1/, and Nos3/
mice. Vaginal plug identification was considered e0.5. Animals were handled
according to institutional guidelines.
In Situ Hybridization
Paraformaldehyde-fixed embryos were processed for in situ hybridization
according to standard zebrafish protocols (http://zfin.org/ZFIN/Methods/
ThisseProtocol.html). The following RNA probes were used: runx1, cmyb,746 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.flk1, ephrinB2, flt4, globin, mpo, mhc, and foxa3. Changes in expression
compared to WT controls are reported as the number altered/number scored
per genotype/treatment (North et al., 2007); a minimum of three independent
experiments was conducted per analysis.
Chemical Exposure
Zebrafish embryos were exposed to chemicals at the doses indicated;
dimethyl sulfoxide (DMSO) carrier content was 0.1%. For evaluation of HSC
development, exposure ranged from early somitogenesis (5+ somites) until
36 hpf, unless otherwise noted.
Morpholino Injection
Morpholino (MO; GeneTools) designed against the ATG and exon1 splice sites
of nos1 (50-ACGCTGGGCTCTGATTCCTGCATTG; 50-TTAATGACATCCCTC
ACCTCTCCAC) and nos2 (50- AGTGGTTTGTGCTTGTCTTCCCATC; 50-ATGC
ATTAGTACCTTTGATTGCACA), and mismatched controls were injected into
one-cell-stage embryos.
Confocal Microscopy
Fluorescent reporter embryos were exposed to blood flow modulators (10 mM,
unless otherwise noted) as indicated, live embedded in 1% agarose,
and imaged with a Zeiss LSM510 Meta confocal microscope at 36 hpf
(North et al., 2007) or a Perkin Elmer UltaVIEW VoX spinning disk confocal
microscope.
qPCR
qPCR was performed on cDNA obtained from whole embryos at 36 hpf (n = 20/
variable; primers listed in Table S1) as previously described (North et al., 2007),
with SYBR Green Supermix on the iQ5 Multicolor RTPCR Detection System
(BioRad).
Blastula Transplantation
cmyb:GFP embryos were injected with nos1 or control MO at the one-cell
stage. At the blastula stage, 100 cells were removed from the donor embryo
and transplanted into stage-matched recipients. Embryos were analyzed by
confocal microscopy at 36 hpf.
Murine AGM Histology
At e11.5 after timed mating, embryos dissected from the uterus and processed
for histological evaluation. Paraffin serial sections were stained with hematox-
ylin and eosin; cryosections were assessed by fluorescence microscopy for
GFP. X-Gal staining was performed as indicated.
Nos3:GFP AGM FACS Analysis
Embryos (e11.5) from Nos3:GFP transgenic animals were isolated, and AGM
tissue was dissected and disaggregated. Flow cytometric analysis was
performed for Nos3:GFP, VE-Cadherin, CD34, Sca-1, c-kit, and CD45 (BD
Pharmingen).
Nos3:GFP AGM Transplantation
Transgenic AGM cells were sorted into Nos3:GFP fractions. AGM (one embryo
equivalent) cell suspensions were injected into irradiated (9 Gy) FVB recipient
mice with adult spleen carrier cells (23 105 per recipient). Recipient peripheral
blood was analyzed at 4 months after transplantation for donor-derived cells
by DNA PCR for GFP (donor marker) and myogenin (normalization control).
Recipients with >10% donor-marked cells were considered positive.
AGM Transplantation and Progenitor and LTR HSC Analysis
AGM transplantations were performed with the CD45.1/45.2 allelic system.
Pregnant C57Bl/6 females were injected with DMSO or L-NAME (2.5 mg/kg)
intraperitoneally on e9.5 and e10.5. WT, L-NAME, Nos1/, and Nos3/
AGM regions were dissected and disaggregated at e11.5 then injected into
8-week-old C57Bl/6 sublethally irradiated recipients. For CFUS8 and 12 anal-
yses, spleens were dissected, weighed, and fixed with Bouin’s solution, and
hematopoietic colonies were counted. For long-term transplants, PB obtained
from recipient mice at 6 weeks was analyzed for donor chimerism and multi-
lineage engraftment (>1%) by FACS.
SUPPLEMENTAL DATA
Supplemental Data include 15 figures and one table and can be found with this
article online at http://www.cell.com/supplemental/S0092-8674(09)00448-6.
ACKNOWLEDGMENTS
We thank M. Lin and J. Loscalzo for helpful suggestions, D. Atochin for assis-
tance with Nos knockout mice, and W. Davis for technical support with spin-
ning-disk confocal microscopy. We thank K.R. Kopani, J. Ojeda, and A.
Meyers for technical assistance with the zebrafish HSC screen. This work
was supported by the National Institutes of Health (T.E.N., W.G., E.D., and
L.I.Z) and a Netherlands Besluit Subsidies Investeringen Kennisinfrastructuur
award (E.D.). L.I.Z. is a Howard Hughes Medical Institute investigator.
Received: September 17, 2008
Revised: December 23, 2008
Accepted: April 7, 2009
Published online: May 13, 2009
REFERENCES
Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-
Ihling, K., Zeiher, A.M., and Dimmeler, S. (2003). Essential role of endothelial
nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.
9, 1370–1376.
Bertrand, J.Y., Kim, A.D., Teng, S., and Traver, D. (2008). CD41+ cmyb+
precursors colonize the zebrafish pronephros by a novel migration route to
initiate adult hematopoiesis. Development 135, 1853–1862.
Burggren, W.W. (2004). What is the purpose of the embryonic heart beat? Or
how facts can ultimately prevail over physiological dogma. Physiol. Biochem.
Zool. 77, 333–345.
Burns, C.E., Traver, D., Mayhall, E., Shepard, J.L., and Zon, L.I. (2005). Hema-
topoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev.
19, 2331–2342.
Davies, P.F. (1995). Flow-mediated endothelial mechanotransduction. Phys-
iol. Rev. 75, 519–560.
de Bruijn, M.F., Speck, N.A., Peeters, M.C., and Dzierzak, E. (2000). Definitive
hematopoietic stem cells first develop within the major arterial regions of the
mouse embryo. EMBO J. 19, 2465–2474.
Downing, J.R., Head, D.R., Curcio-Brint, A.M., Hulshof, M.G., Motroni, T.A.,
Raimondi, S.C., Carroll, A.J., Drabkin, H.A., Willman, C., Theil, K.S., et al.
(1993). An AML1/ETO fusion transcript is consistently detected by RNA-based
polymerase chain reaction in acute myelogenous leukemia containing the
(8;21)(q22;q22) translocation. Blood 81, 2860–2865.
Du, Q., Park, K.S., Guo, Z., He, P., Nagashima, M., Shao, L., Sahai, R., Geller,
D.A., and Hussain, S.P. (2006). Regulation of human nitric oxide synthase 2
expression by Wnt beta-catenin signaling. Cancer Res. 66, 7024–7031.
Duran-Reyes, G., Gomez-Melendez, M.R., Morali-de la Brena, G., Mercado-
Pichardo, E., Medina-Navarro, R., and Hicks-Gomez, J.J. (1999). Nitric oxide
synthesis inhibition suppresses implantation and decreases cGMP concentra-
tion and protein peroxidation. Life Sci. 65, 2259–2268.
Dzierzak, E., and Medvinsky, A. (2008). The discovery of a source of adult
hematopoietic cells in the embryo. Development 135, 2343–2346.
Dzierzak, E., and Speck, N.A. (2008). Of lineage and legacy: the development
of mammalian hematopoietic stem cells. Nat. Immunol. 9, 129–136.
Eddy, F.B. (2005). Role of nitric oxide in larval and juvenile fish. Comp.
Biochem. Physiol. A Mol. Integr. Physiol. 142, 221–230.
Epperly, M.W., Cao, S., Zhang, X., Franicola, D., Shen, H., Greenberger, E.E.,
Epperly, L.D., and Greenberger, J.S. (2007). Increased longevity of hematopoi-
esis in continuous bone marrow cultures derived from NOS1 (nNOS, mtNOS)
homozygous recombinant negative mice correlates with radioresistance of
hematopoietic and marrow stromal cells. Exp. Hematol. 35, 137–145.Fritsche, R., Schwerte, T., and Pelster, B. (2000). Nitric oxide and vascular
reactivity in developing zebrafish, Danio rerio. Am. J. Physiol. Regul. Integr.
Comp. Physiol. 279, R2200–R2207.
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.O., Buerk,
D.G., Huang, P.L., and Jain, R.K. (2001). Predominant role of endothelial nitric
oxide synthase in vascular endothelial growth factor-induced angiogenesis
and vascular permeability. Proc. Natl. Acad. Sci. USA 98, 2604–2609.
Goessling, W., North, T.E., Lord, A.M., Ceol, C., Lee, S., Weidinger, G., Bour-
que, C., Strijbosch, R., Haramis, A.P., Puder, M., et al. (2008). APC mutant ze-
brafish uncover a changing temporal requirement for wnt signaling in liver
development. Dev. Biol. 320, 161–174.
Goessling, W., North, T.E., Loewer, S., Lord, A.M., Lee, S., Stoick-Cooper,
C.L., Weidinger, G., Puder, M., Daley, G.Q., Moon, R.T., et al. (2009). Genetic
interaction of PGE2 and Wnt signaling regulates developmental specification
of stem cells and regeneration. Cell 136, 1136–1147.
Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-
Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D., and Gilliland, D.G.
(1995). Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute
lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92, 4917–4921.
Holmqvist, B., Ellingsen, B., Forsell, J., Zhdanova, I., and Alm, P. (2004). The
early ontogeny of neuronal nitric oxide synthase systems in the zebrafish.
J. Exp. Biol. 207, 923–935.
Ishimura, N., Bronk, S.F., and Gores, G.J. (2005). Inducible nitric oxide syn-
thase up-regulates Notch-1 in mouse cholangiocytes: implications for carcino-
genesis. Gastroenterology 128, 1354–1368.
Isogai, S., Lawson, N.D., Torrealday, S., Horiguchi, M., and Weinstein, B.M.
(2003). Angiogenic network formation in the developing vertebrate trunk.
Development 130, 5281–5290.
Itoh, M., Kim, C.H., Palardy, G., Oda, T., Jiang, Y.J., Maust, D., Yeo, S.Y.,
Lorick, K., Wright, G.J., Ariza-McNaughton, L., et al. (2003). Mind bomb is
a ubiquitin ligase that is essential for efficient activation of Notch signaling
by Delta. Dev. Cell 4, 67–82.
Jin, H., Sood, R., Xu, J., Zhen, F., English, M.A., Liu, P.P., and Wen, Z. (2009).
Definitive hematopoietic stem/progenitor cells manifest distinct differentiation
output in the zebrafish VDA and PBI. Development 136, 647–654.
Krasnov, P., Michurina, T., Packer, M.A., Stasiv, Y., Nakaya, N., Moore, K.A.,
Drazan, K.E., and Enikolopov, G. (2008). Neuronal nitric oxide synthase
contributes to the regulation of hematopoiesis. Mol. Med. 14, 141–149.
Lawson, N.D., Scheer, N., Pham, V.N., Kim, C.H., Chitnis, A.B., Campos-
Ortega, J.A., and Weinstein, B.M. (2001). Notch signaling is required for
arterial-venous differentiation during embryonic vascular development. Devel-
opment 128, 3675–3683.
Lawson, N.D., and Weinstein, B.M. (2002). In vivo imaging of embryonic
vascular development using transgenic zebrafish. Dev. Biol. 248, 307–318.
Lucitti, J.L., Jones, E.A., Huang, C., Chen, J., Fraser, S.E., and Dickinson, M.E.
(2007). Vascular remodeling of the mouse yolk sac requires hemodynamic
force. Development 134, 3317–3326.
Lux, C.T., Yoshimoto, M., McGrath, K., Conway, S.J., Palis, J., and Yoder,
M.C. (2008). All primitive and definitive hematopoietic progenitor cells
emerging before E10 in the mouse embryo are products of the yolk sac. Blood
111, 3435–3438.
Michurina, T., Krasnov, P., Balazs, A., Nakaya, N., Vasilieva, T., Kuzin, B.,
Khrushchov, N., Mulligan, R.C., and Enikolopov, G. (2004). Nitric oxide is
a regulator of hematopoietic stem cell activity. Mol. Ther. 10, 241–248.
Murayama, E., Kissa, K., Zapata, A., Mordelet, E., Briolat, V., Lin, H.F., Handin,
R.I., and Herbomel, P. (2006). Tracing hematopoietic precursor migration to
successive hematopoietic organs during zebrafish development. Immunity
25, 963–975.
Nath, A.K., Enciso, J., Kuniyasu, M., Hao, X.Y., Madri, J.A., and Pinter, E.
(2004). Nitric oxide modulates murine yolk sac vasculogenesis and rescues
glucose induced vasculopathy. Development 131, 2485–2496.Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc. 747
Noiri, E., Lee, E., Testa, J., Quigley, J., Colflesh, D., Keese, C.R., Giaever, I.,
and Goligorsky, M.S. (1998). Podokinesis in endothelial cell migration: role of
nitric oxide. Am. J. Physiol. 274, C236–C244.
North, T., Gu, T.L., Stacy, T., Wang, Q., Howard, L., Binder, M., Marin-Padilla,
M., and Speck, N.A. (1999). Cbfa2 is required for the formation of intra-aortic
hematopoietic clusters. Development 126, 2563–2575.
North, T.E., de Bruijn, M.F., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder,
M., Dzierzak, E., and Speck, N.A. (2002). Runx1 expression marks long-term
repopulating hematopoietic stem cells in the midgestation mouse embryo.
Immunity 16, 661–672.
North, T.E., Goessling, W., Walkley, C.R., Lengerke, C., Kopani, K.R., Lord,
A.M., Weber, G.J., Bowman, T.V., Jang, I.H., Grosser, T., et al. (2007). Prosta-
glandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature
447, 1007–1011.
Orkin, S.H., and Zon, L.I. (2008). Hematopoiesis: an evolving paradigm for
stem cell biology. Cell 132, 631–644.
Palis, J., and Yoder, M.C. (2001). Yolk-sac hematopoiesis: the first blood cells
of mouse and man. Exp. Hematol. 29, 927–936.
Pallares, P., Garcia-Fernandez, R.A., Criado, L.M., Letelier, C.A., Esteban, D.,
Fernandez-Toro, J.M., Flores, J.M., and Gonzalez-Bulnes, A. (2008). Disrup-
tion of the endothelial nitric oxide synthase gene affects ovulation, fertilization
and early embryo survival in a knockout mouse model. Reproduction 136,
573–579.
Pelster, B., and Burggren, W.W. (1996). Disruption of hemoglobin oxygen
transport does not impact oxygen-dependent physiological processes in
developing embryos of zebra fish (Danio rerio). Circ. Res. 79, 358–362.
Pelster, B., Grillitsch, S., and Schwerte, T. (2005). NO as a mediator during
the early development of the cardiovascular system in the zebrafish. Comp.
Biochem. Physiol. A Mol. Integr. Physiol. 142, 215–220.
Poon, K.L., Richardson, M., Lam, C.S., Khoo, H.E., and Korzh, V. (2003).
Expression pattern of neuronal nitric oxide synthase in embryonic zebrafish.
Gene Expr. Patterns 3, 463–466.
Prevotat, L., Filomenko, R., Solary, E., Jeannin, J.F., and Bettaieb, A. (2006).
Nitric oxide-induced down-regulation of beta-catenin in colon cancer cells748 Cell 137, 736–748, May 15, 2009 ª2009 Elsevier Inc.by a proteasome-independent specific pathway. Gastroenterology 131,
1142–1152.
Pyriochou, A., Beis, D., Koika, V., Potytarchou, C., Papadimitriou, E., Zhou, Z.,
and Papapetropoulos, A. (2006). Soluble guanylyl cyclase activation promotes
angiogenesis. J. Pharmacol. Exp. Ther. 319, 663–671.
Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz,
L., Nusse, R., and Weissman, I.L. (2003). A role for Wnt signalling in self-
renewal of haematopoietic stem cells. Nature 423, 409–414.
Rhodes, K.E., Gekas, C., Wang, Y., Lux, C.T., Francis, C.S., Chan, D.N., Con-
way, S., Orkin, S.H., Yoder, M.C., and Mikkola, H.K. (2008). The emergence of
hematopoietic stem cells is initiated in the placental vasculature in the absence
of circulation. Cell Stem Cell 2, 252–263.
Sehnert, A.J., Huq, A., Weinstein, B.M., Walker, C., Fishman, M., and Stainier,
D.Y. (2002). Cardiac troponin T is essential in sarcomere assembly and cardiac
contractility. Nat. Genet. 31, 106–110.
Teichert, A.M., Scott, J.A., Robb, G.B., Zhou, Y.Q., Zhu, S.N., Lem, M., Keight-
ley, A., Steer, B.M., Schuh, A.C., Adamson, S.L., et al. (2008). Endothelial nitric
oxide synthase gene expression during murine embryogenesis: commence-
ment of expression in the embryo occurs with the establishment of a unidirec-
tional circulatory system. Circ. Res. 103, 24–33.
van Haperen, R., Cheng, C., Mees, B.M., van Deel, E., de Waard, M., van
Damme, L.C., van Gent, T., van Aken, T., Krams, R., Duncker, D.J., et al.
(2003). Functional expression of endothelial nitric oxide synthase fused to
green fluorescent protein in transgenic mice. Am. J. Pathol. 163, 1677–1686.
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H., and Speck,
N.A. (1996). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging
in the central nervous system and blocks definitive hematopoiesis. Proc. Natl.
Acad. Sci. USA 93, 3444–3449.
Weber, G.J., Choe, S.E., Dooley, K.A., Paffett-Lugassy, N.N., Zhou, Y., and
Zon, L.I. (2005). Mutant-specific gene programs in the zebrafish. Blood 106,
521–530.
White, C.R., and Frangos, J.A. (2007). The shear stress of it all: the cell
membrane and mechanochemical transduction. Philos. Trans. R. Soc. Lond.
B Biol. Sci. 362, 1459–1467.
